In a recent SEC filing, Andre Schulten, the Chief Financial Officer of Procter & Gamble, disclosed significant stock transactions that underscore his commitment to the company. This filing, dated October 5, 2026, is particularly notable as it reveals Schulten's ongoing investment in Procter & Gamble, a leader in the consumer goods sector.
Schulten reported acquiring 6,557 shares of Procter & Gamble's common stock on October 1, 2026. Following this transaction, he owns a total of 69,532 shares directly. Additionally, he holds 78,324 shares through stock options, which he can exercise at a price of $143.95 per share. These transactions reflect a strategic move by Schulten, indicating his confidence in the company's future performance.
Background
Procter & Gamble Co, identified by CIK 0000080424, is a prominent player in the soap, detergent, and cleaning preparations sector, classified under the SIC code 2840. The company is headquartered at One Procter & Gamble Plaza, Cincinnati, OH, and is publicly traded on major exchanges. In recent filings, Schulten has consistently reported his stock transactions, demonstrating a proactive approach to his equity holdings.
What the Filing Says
The SEC filing reveals that Schulten acquired 6,557 shares of common stock on October 1, 2026, with a total of 69,532 shares owned following this transaction. Additionally, he holds 78,324 shares through stock options, which he can exercise until 2036. The filing states, "Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan." This indicates that part of his compensation is tied to the company's performance, aligning his interests with those of shareholders.
Impact
These transactions may influence investor sentiment and employee morale within Procter & Gamble. Schulten's actions could signal to other executives and employees the importance of investing in the company's future, potentially leading to a more engaged workforce. Additionally, competitors in the consumer goods sector may observe these developments as they assess their own executive compensation strategies and stock ownership policies.
What's Next
The filing does not specify what happens next regarding Schulten's stock options or any further transactions. However, given the nature of executive stock ownership, further disclosures may be anticipated in the coming months as Schulten continues to navigate his role at Procter & Gamble.